|  Help  |  About  |  Contact Us

Search our database by keyword

Examples

  • Search this entire website. Enter identifiers, names or keywords for genes, diseases, strains, ontology terms, etc. (e.g. Pax6, Parkinson, ataxia)
  • Use OR to search for either of two terms (e.g. OR mus) or quotation marks to search for phrases (e.g. "dna binding").
  • Boolean search syntax is supported: e.g. Balb* for partial matches or mus AND NOT embryo to exclude a term

Search results 1 to 100 out of 100 for Gpr18

0.036s
Type Details Score
Gene
Type: gene
Organism: human
Gene
Type: gene
Organism: chimpanzee
Gene
Type: gene
Organism: cattle
Gene
Type: gene
Organism: chicken
Gene
Type: gene
Organism: zebrafish
Gene
Type: gene
Organism: macaque, rhesus
Gene
Type: gene
Organism: frog, western clawed
Gene
Type: gene
Organism: dog, domestic
Gene
Type: gene
Organism: rat
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Domain
Type: Family
Description: Several 7TM receptors have been cloned but their endogenous ligands are unknown; these have been termed orphan receptors. However, recent research has identified certain pharmacological targets that could be investigated to find, for example, new potential cannabinoid receptors or channels [, , ]. GPR18 [, ], GPR55 [, ], GPR119 []show little structural similarity to CB1 and CB2 receptors, but they respond to endogenous agents analogous to the endogenous cannabinoid ligands, as well as some natural/synthetic cannabinoid receptor ligands []. However, because they do not fulfill all of the cannabinoid receptor criteria defined by IUPHAR, the classification of these proteins remains a contentious issue due to conflicting pharmacological results. As a result, they remain classified as putative endogenous agonists by IUPHAR [].This entry represents G protein-coupled receptor 18, also known as N-arachidonyl glycine receptor. It has been found to be a receptor for endogenous lipid neurotransmitters, several of which also bind to cannabinoid receptors [, , , ]. Recent research also supports the hypothesis that GPR18 is the abnormal cannabidiol receptor and N-arachidonoyl glycine, the endogenous lipid metabolite of anandamide, initiates directed microglial migration in the CNS through activation of GPR18 []. However, the pairing of GPR18 with N-arachidonoylglycine (NAGly) and tetrahydrocannabinol (THC) was not reproduced in two studies based on beta-arrestin assays [, ]. So, until further research allows a more definitive decision the function and nomenclature GPR18 is still being debated [, ].
Publication
First Author: Alexander SP
Year: 2012
Journal: Br J Pharmacol
Title: So what do we call GPR18 now?
Volume: 165
Issue: 8
Pages: 2411-3
Publication
First Author: Becker AM
Year: 2015
Journal: PLoS One
Title: GPR18 Controls Reconstitution of Mouse Small Intestine Intraepithelial Lymphocytes following Bone Marrow Transplantation.
Volume: 10
Issue: 7
Pages: e0133854
Publication
First Author: Wang X
Year: 2014
Journal: J Exp Med
Title: GPR18 is required for a normal CD8αα intestinal intraepithelial lymphocyte compartment.
Volume: 211
Issue: 12
Pages: 2351-9
Publication  
First Author: Dicker M
Year: 2022
Journal: Front Immunol
Title: CD4(+)-mediated colitis in mice is independent of the GPR183 and GPR18 pathways.
Volume: 13
Pages: 1034648
Publication
First Author: Miller S
Year: 2016
Journal: Invest Ophthalmol Vis Sci
Title: Evidence for a GPR18 Role in Diurnal Regulation of Intraocular Pressure.
Volume: 57
Issue: 14
Pages: 6419-6426
Publication
First Author: Samuelson LC
Year: 1996
Journal: Mamm Genome
Title: Mapping of the novel G protein-coupled receptor Gpr18 to distal mouse chromosome 14.
Volume: 7
Issue: 12
Pages: 920-1
Publication
First Author: McHugh D
Year: 2012
Journal: Br J Pharmacol
Title: Δ(9) -Tetrahydrocannabinol and N-arachidonyl glycine are full agonists at GPR18 receptors and induce migration in human endometrial HEC-1B cells.
Volume: 165
Issue: 8
Pages: 2414-24
Publication
First Author: Kohno M
Year: 2006
Journal: Biochem Biophys Res Commun
Title: Identification of N-arachidonylglycine as the endogenous ligand for orphan G-protein-coupled receptor GPR18.
Volume: 347
Issue: 3
Pages: 827-32
Publication
First Author: Burstein S
Year: 2008
Journal: Neuropharmacology
Title: The elmiric acids: biologically active anandamide analogs.
Volume: 55
Issue: 8
Pages: 1259-64
Publication
First Author: Bradshaw HB
Year: 2009
Journal: Prostaglandins Other Lipid Mediat
Title: Orphan endogenous lipids and orphan GPCRs: a good match.
Volume: 89
Issue: 3-4
Pages: 131-4
Publication
First Author: Southern C
Year: 2013
Journal: J Biomol Screen
Title: Screening β-arrestin recruitment for the identification of natural ligands for orphan G-protein-coupled receptors.
Volume: 18
Issue: 5
Pages: 599-609
Publication
First Author: Yin H
Year: 2009
Journal: J Biol Chem
Title: Lipid G protein-coupled receptor ligand identification using beta-arrestin PathHunter assay.
Volume: 284
Issue: 18
Pages: 12328-38
Publication
First Author: Davenport AP
Year: 2013
Journal: Pharmacol Rev
Title: International Union of Basic and Clinical Pharmacology. LXXXVIII. G protein-coupled receptor list: recommendations for new pairings with cognate ligands.
Volume: 65
Issue: 3
Pages: 967-86
Publication  
First Author: McHugh D
Year: 2010
Journal: BMC Neurosci
Title: N-arachidonoyl glycine, an abundant endogenous lipid, potently drives directed cellular migration through GPR18, the putative abnormal cannabidiol receptor.
Volume: 11
Pages: 44
Publication
First Author: Ryberg E
Year: 2007
Journal: Br J Pharmacol
Title: The orphan receptor GPR55 is a novel cannabinoid receptor.
Volume: 152
Issue: 7
Pages: 1092-101
Publication
First Author: Pertwee RG
Year: 2007
Journal: Br J Pharmacol
Title: GPR55: a new member of the cannabinoid receptor clan?
Volume: 152
Issue: 7
Pages: 984-6
Publication
First Author: Izzo AA
Year: 2010
Journal: Pharmacol Ther
Title: Cannabinoids and the gut: new developments and emerging concepts.
Volume: 126
Issue: 1
Pages: 21-38
Publication
First Author: Brown AJ
Year: 2007
Journal: Br J Pharmacol
Title: Novel cannabinoid receptors.
Volume: 152
Issue: 5
Pages: 567-75
Protein
Organism: Mus musculus/domesticus
Length: 331  
Fragment?: false
Publication
First Author: Pertwee RG
Year: 2010
Journal: Pharmacol Rev
Title: International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB₁ and CB₂.
Volume: 62
Issue: 4
Pages: 588-631
Publication  
First Author: Sumida H
Year: 2018
Journal: Front Immunol
Title: G-Protein Coupled Receptor 18 Contributes to Establishment of the CD8 Effector T Cell Compartment.
Volume: 9
Pages: 660
Publication
First Author: Chiang N
Year: 2015
Journal: J Exp Med
Title: Identification of resolvin D2 receptor mediating resolution of infections and organ protection.
Volume: 212
Issue: 8
Pages: 1203-17
Publication
First Author: Fitzgerald H
Year: 2023
Journal: Am J Pathol
Title: Resolvin D2-G-Protein Coupled Receptor 18 Enhances Bone Marrow Function and Limits Steatosis and Hepatic Collagen Accumulation in Aging.
Volume: 193
Issue: 12
Pages: 1953-1968
Publication
First Author: Dort J
Year: 2021
Journal: Nat Commun
Title: Resolvin-D2 targets myogenic cells and improves muscle regeneration in Duchenne muscular dystrophy.
Volume: 12
Issue: 1
Pages: 6264
Protein Coding Gene
Type: protein_coding_gene
Organism: Mus caroli
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: Mus pahari
Protein Coding Gene
Type: protein_coding_gene
Organism: Mus spretus
Publication
First Author: Chiang N
Year: 2017
Journal: J Immunol
Title: Novel Resolvin D2 Receptor Axis in Infectious Inflammation.
Volume: 198
Issue: 2
Pages: 842-851
Publication
First Author: Hellmann J
Year: 2018
Journal: J Invest Dermatol
Title: Biosynthesis of D-Series Resolvins in Skin Provides Insights into their Role in Tissue Repair.
Volume: 138
Issue: 9
Pages: 2051-2060
Publication
First Author: Zhang MJ
Year: 2016
Journal: Circulation
Title: Resolvin D2 Enhances Postischemic Revascularization While Resolving Inflammation.
Volume: 134
Issue: 9
Pages: 666-680
Publication
First Author: Joffre J
Year: 2020
Journal: J Immunol
Title: Activation of CB1R Promotes Lipopolysaccharide-Induced IL-10 Secretion by Monocytic Myeloid-Derived Suppressive Cells and Reduces Acute Inflammation and Organ Injury.
Volume: 204
Issue: 12
Pages: 3339-3350
Publication      
First Author: The Jackson Laboratory Backcross DNA Panel Mapping Resource
Year: 1999
Journal: Database Release
Title: JAX BSS Panel Mapping Data
Publication        
First Author: Mouse Genome Informatics Scientific Curators
Year: 2002
Title: MGC Data curation in Mouse Genome Informatics
Publication      
First Author: Velocigene
Year: 2008
Journal: MGI Direct Data Submission
Title: Alleles produced for the KOMP project by Velocigene (Regeneron Pharmaceuticals)
Publication        
First Author: Cyagen Biosciences Inc.
Year: 2022
Title: Cyagen Biosciences Website.
Publication        
First Author: UniProt-GOA
Year: 2012
Title: Gene Ontology annotation based on UniProtKB/Swiss-Prot Subcellular Location vocabulary mapping, accompanied by conservative changes to GO terms applied by UniProt
Publication
First Author: Magdaleno S
Year: 2006
Journal: PLoS Biol
Title: BGEM: an in situ hybridization database of gene expression in the embryonic and adult mouse nervous system.
Volume: 4
Issue: 4
Pages: e86
Publication
First Author: Carninci P
Year: 2005
Journal: Science
Title: The transcriptional landscape of the mammalian genome.
Volume: 309
Issue: 5740
Pages: 1559-63
Publication        
First Author: GemPharmatech
Year: 2020
Title: GemPharmatech Website.
Publication        
First Author: UniProt-GOA
Year: 2012
Title: Gene Ontology annotation based on UniProtKB/Swiss-Prot keyword mapping
Publication      
First Author: The Jackson Laboratory Mouse Radiation Hybrid Database
Year: 2004
Journal: Database Release
Title: Mouse T31 Radiation Hybrid Data Load
Publication        
First Author: Mouse Genome Informatics Scientific Curators
Year: 2002
Title: Mouse Genome Informatics Computational Sequence to Gene Associations
Publication      
First Author: MGI Genome Annotation Group and UniGene Staff
Year: 2015
Journal: Database Download
Title: MGI-UniGene Interconnection Effort
Publication      
First Author: Mouse Genome Informatics Scientific Curators
Year: 2010
Journal: Database Download
Title: Mouse Microarray Data Integration in Mouse Genome Informatics, the Affymetrix GeneChip Mouse Genome U74 Array Platform (A, B, C v2).
Publication        
First Author: Marc Feuermann, Huaiyu Mi, Pascale Gaudet, Dustin Ebert, Anushya Muruganujan, Paul Thomas
Year: 2010
Title: Annotation inferences using phylogenetic trees
Publication      
First Author: Mouse Genome Database and National Center for Biotechnology Information
Year: 2000
Journal: Database Release
Title: Entrez Gene Load
Publication      
First Author: Bairoch A
Year: 1999
Journal: Database Release
Title: SWISS-PROT Annotated protein sequence database
Publication        
First Author: Mouse Genome Informatics Scientific Curators
Year: 2005
Title: Obtaining and loading genome assembly coordinates from NCBI annotations
Publication      
First Author: Mouse Genome Informatics Group
Year: 2003
Journal: Database Procedure
Title: Automatic Encodes (AutoE) Reference
Publication      
First Author: Mouse Genome Informatics (MGI) and The National Center for Biotechnology Information (NCBI)
Year: 2010
Journal: Database Download
Title: Consensus CDS project
Publication      
First Author: Mouse Genome Informatics
Year: 2010
Journal: Database Release
Title: Protein Ontology Association Load.
Publication        
First Author: Mouse Genome Informatics Scientific Curators
Year: 2005
Title: Obtaining and Loading Genome Assembly Coordinates from Ensembl Annotations
Publication      
First Author: Mouse Genome Informatics Scientific Curators
Year: 2009
Journal: Database Download
Title: Mouse Microarray Data Integration in Mouse Genome Informatics, the Affymetrix GeneChip Mouse Gene 1.0 ST Array Platform
Publication      
First Author: Allen Institute for Brain Science
Year: 2004
Journal: Allen Institute
Title: Allen Brain Atlas: mouse riboprobes
Publication      
First Author: Mouse Genome Informatics Scientific Curators
Year: 2009
Journal: Database Download
Title: Mouse Microarray Data Integration in Mouse Genome Informatics, the Affymetrix GeneChip Mouse Genome 430 2.0 Array Platform
Publication  
First Author: Reyes-Resina I
Year: 2018
Journal: Biochem Pharmacol
Title: Molecular and functional interaction between GPR18 and cannabinoid CB2 G-protein-coupled receptors. Relevance in neurodegenerative diseases.
Volume: 157
Pages: 169-179
Publication
First Author: Whyte LS
Year: 2009
Journal: Proc Natl Acad Sci U S A
Title: The putative cannabinoid receptor GPR55 affects osteoclast function in vitro and bone mass in vivo.
Volume: 106
Issue: 38
Pages: 16511-6
Protein Domain
Type: Family
Description: Several 7TM receptors have been cloned but theirendogenous ligands are unknown; these have been termed orphan receptors. However, recent research has identified certain pharmacological targets that could be investigated to find, for example, new potential cannabinoid receptors or channels [, , ]. GPR18 [, ], GPR55 [, ], GPR119 []show little structural similarity to CB1 and CB2 receptors, but they respond to endogenous agents analogous to the endogenous cannabinoid ligands, as well as some natural/synthetic cannabinoid receptor ligands []. However, because they do not fulfill all of the cannabinoid receptor criteria defined by IUPHAR, the classification of these proteins remains a contentious issue due to conflicting pharmacological results. As a result, they remain classified as putative endogenous agonists by IUPHAR [].This entry represents G protein-coupled receptor 55. It is thought to play a role in bone physiology by regulating osteoclast number and function [].
Publication
First Author: Miller S
Year: 2018
Journal: Invest Ophthalmol Vis Sci
Title: Δ9-Tetrahydrocannabinol and Cannabidiol Differentially Regulate Intraocular Pressure.
Volume: 59
Issue: 15
Pages: 5904-5911
Publication  
First Author: Taylor L
Year: 2015
Journal: Sci Rep
Title: Primary Macrophage Chemotaxis Induced by Cannabinoid Receptor 2 Agonists Occurs Independently of the CB2 Receptor.
Volume: 5
Pages: 10682
Publication
First Author: Soga T
Year: 2005
Journal: Biochem Biophys Res Commun
Title: Lysophosphatidylcholine enhances glucose-dependent insulin secretion via an orphan G-protein-coupled receptor.
Volume: 326
Issue: 4
Pages: 744-51
Publication
First Author: Chu ZL
Year: 2007
Journal: Endocrinology
Title: A role for beta-cell-expressed G protein-coupled receptor 119 in glycemic control by enhancing glucose-dependent insulin release.
Volume: 148
Issue: 6
Pages: 2601-9
Publication
First Author: Overton HA
Year: 2006
Journal: Cell Metab
Title: Deorphanization of a G protein-coupled receptor for oleoylethanolamide and its use in the discovery of small-molecule hypophagic agents.
Volume: 3
Issue: 3
Pages: 167-75
Publication
First Author: Ning Y
Year: 2008
Journal: Br J Pharmacol
Title: Endogenous and synthetic agonists of GPR119 differ in signalling pathways and their effects on insulin secretion in MIN6c4 insulinoma cells.
Volume: 155
Issue: 7
Pages: 1056-65
Publication
First Author: Swaminath G
Year: 2008
Journal: Arch Pharm (Weinheim)
Title: Fatty acid binding receptors and their physiological role in type 2 diabetes.
Volume: 341
Issue: 12
Pages: 753-61
Publication
First Author: Lan H
Year: 2009
Journal: J Endocrinol
Title: GPR119 is required for physiological regulation of glucagon-like peptide-1 secretion but not for metabolic homeostasis.
Volume: 201
Issue: 2
Pages: 219-30
Publication  
First Author: Overton HA
Year: 2008
Journal: Br J Pharmacol
Title: GPR119, a novel G protein-coupled receptor target for the treatment of type 2 diabetes and obesity.
Volume: 153 Suppl 1
Pages: S76-81
Publication
First Author: Chu ZL
Year: 2010
Journal: Mol Endocrinol
Title: N-oleoyldopamine enhances glucose homeostasis through the activation of GPR119.
Volume: 24
Issue: 1
Pages: 161-70
Protein Domain
Type: Family
Description: Several 7TM receptors have been cloned but their endogenous ligands are unknown; these have been termed orphan receptors. However, recent research has identified certain pharmacological targets that could be investigated to find, for example, new potential cannabinoid receptors or channels [, , ]. GPR18 [, ], GPR55 [, ], GPR119 []show little structural similarity to CB1 and CB2 receptors, but they respond to endogenous agents analogous to the endogenous cannabinoid ligands, as well as some natural/synthetic cannabinoid receptor ligands []. However, because they do not fulfill all of the cannabinoid receptor criteria defined by IUPHAR, the classification of these proteins remains a contentious issue due to conflicting pharmacological results. As a result, they remain classified as putative endogenous agonists by IUPHAR [].This entry represents glucose-dependent insulinotropic receptor, also known as G protein-coupled receptor 119. It is expressed predominantly in the pancreas and gastrointestinal tract in rodents and humans, as well as in the brain in rodents []. It has been shown to be involved in the control of glucose-dependent insulin release and glucagon-like peptide 1 release, respectively [, ], which caused a reduction in food intake and body weight gain in rats []. GPR119 has also been shown to regulate incretin and insulin hormone secretion [, , ], behaving as a glucose-dependent insulinotropic receptor. As a result, new drugs acting on the receptor have been suggested as novel treatments for obesity and diabetes [, , ]. Although GPR119 is phylogenetically related to cannabinoid receptors, only fatty acid amides interact with GPR119 [, , , ]. The potency order is N-oleoyl dopamine >oleoyl ethanolamide >palmitoyl ethanolamide >anandamide [, ]. However, because only N-oleoyl dopamine and oleoyl ethanolamide have reasonably high (low micromolar) affinity for GPR119, and because neither of these lipids interacts with CB1 or CB2 receptors, GPR119 cannot currently be viewed as a cannabinoid receptor [].
Protein
Organism: Mus musculus/domesticus
Length: 335  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 327  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 327  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 327  
Fragment?: false